| 000 | 01636 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516201523.0 | ||
| 264 | 0 | _c20140506 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVénat-Bouvet, Laurence | |
| 245 | 0 | 0 |
_aAdjuvant chemotherapy in node-negative breast cancer: UPA/PAI-1 determinations for 163 cases. _h[electronic resource] |
| 260 |
_bAnticancer research _cMar 2014 |
||
| 300 |
_a1213-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Nodes _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xmetabolism |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xmetabolism |
| 700 | 1 | _aFermeaux, Veronique | |
| 700 | 1 | _aLeobon, Sophie | |
| 700 | 1 | _aSaidi, Nadira | |
| 700 | 1 | _aMonteil, Jacques | |
| 700 | 1 | _aMollard, Joelle | |
| 700 | 1 | _aAubard, Yves | |
| 700 | 1 | _aJammet, Isabelle | |
| 700 | 1 | _aTubiana-Mathieu, Nicole | |
| 773 | 0 |
_tAnticancer research _gvol. 34 _gno. 3 _gp. 1213-7 |
|
| 999 |
_c23610657 _d23610657 |
||